Sequel Med Tech connects twiist insulin pump to Abbott’s CGM ahead of market debut
Greenlit for people ages six and older with Type 1 diabetes, Sequel’s twiist system is slated to begin its commercial launch by the end of June.

Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 16, 2025 0
Mar 16, 2025 0
Mar 16, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Mar 18, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 11, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.